Actionable news
All posts from Actionable news
Actionable news in ABIO: ARCA biopharma, Inc.,

ARCA biopharma to Present at the 27

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it will make a presentation at the 27th Annual Piper Jaffray Healthcare Conference.


Tuesday, December 1, 2015


8:10 a.m. (Eastern Time)


Thomas Keuer, Chief Operating Officer


The live webcast and accompanying slides will be available at and, respectively.

Replay Information:

A replay is expected to be available approximately two hours after the presentation on December 1, 2015, and will remain available for 90 days. The replay can be accessed at

About ARCA biopharma

ARCA biopharma is dedicated to developing genetically-targeted therapies for cardiovascular diseases. The Company's lead...